O Keefe Stevens Advisory Inc. Purchases 37,718 Shares of Sotera Health Company $SHC

O Keefe Stevens Advisory Inc. grew its position in Sotera Health Company (NASDAQ:SHC) by 4.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 838,114 shares of the company’s stock after buying an additional 37,718 shares during the period. Sotera Health accounts for approximately 3.3% of O Keefe Stevens Advisory Inc.’s investment portfolio, making the stock its 13th largest holding. O Keefe Stevens Advisory Inc.’s holdings in Sotera Health were worth $15,497,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Militia Capital Management LLC bought a new stake in Sotera Health in the 1st quarter valued at $3,877,000. Public Employees Retirement System of Ohio bought a new stake in Sotera Health in the 2nd quarter valued at about $1,440,000. Bank of New York Mellon Corp grew its position in shares of Sotera Health by 13.4% during the 1st quarter. Bank of New York Mellon Corp now owns 1,403,971 shares of the company’s stock worth $20,133,000 after purchasing an additional 166,055 shares in the last quarter. Balefire LLC bought a new position in shares of Sotera Health during the first quarter worth approximately $1,476,000. Finally, BlackRock Inc. bought a new position in shares of Sotera Health during the second quarter worth approximately $428,635,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on SHC. Barclays boosted their price target on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. JPMorgan Chase & Co. increased their target price on Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a research note on Tuesday, September 8th. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. Finally, UBS Group set a $19.00 target price on shares of Sotera Health in a research report on Wednesday, June 24th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $21.50.

Sotera Health Price Performance

SHC stock traded up $0.26 during midday trading on Friday, reaching $18.09. 409,907 shares of the stock were exchanged, compared to its average volume of 2,724,001. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85. The company has a fifty day moving average price of $18.70 and a 200 day moving average price of $17.00. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. The stock has a market capitalization of $5.16 billion, a PE ratio of 31.75 and a beta of 1.85.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same period last year, the firm posted $0.20 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, analysts expect that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 in the last ninety days. Insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.